ZILBRYSQ Trademark

Trademark Overview

On Thursday, October 29, 2020, a trademark application was filed for ZILBRYSQ with the United States Patent and Trademark Office. The USPTO has given the ZILBRYSQ trademark a serial number of 90286947. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Ra Pharmaceuticals, Inc.. The ZILBRYSQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis
zilbrysq

General Information

Serial Number90286947
Word MarkZILBRYSQ
Filing DateThursday, October 29, 2020
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7305051
Registration DateTuesday, February 13, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Description of MarkThe mark consists of the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending at the tail of the "Q".
Goods and ServicesPharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis
Indication of Colors claimedThe color(s) blue, orange, and red is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 21, 2020
Primary Code005
First Use Anywhere DateWednesday, January 3, 2024
First Use In Commerce DateWednesday, January 3, 2024

Trademark Owner History

Party NameUCB HOLDINGS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSMYRNA, GA 30080
Party NameRa Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameRa Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameRa Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Monday, December 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 2, 2020NEW APPLICATION ENTERED
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Thursday, April 1, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, April 1, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, April 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 1, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, April 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 25, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 13, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 13, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 13, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 21, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 21, 2021SOU EXTENSION 1 FILED
Tuesday, December 21, 2021SOU EXTENSION 1 GRANTED
Thursday, December 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 15, 2022SOU EXTENSION 2 FILED
Wednesday, June 15, 2022SOU EXTENSION 2 GRANTED
Tuesday, September 20, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 20, 2022SOU EXTENSION 3 FILED
Tuesday, September 20, 2022SOU EXTENSION 3 GRANTED
Thursday, September 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 4 FILED
Friday, March 31, 2023SOU EXTENSION 4 GRANTED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 5 FILED
Tuesday, November 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 28, 2023SOU EXTENSION 5 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 8, 2024USE AMENDMENT FILED
Monday, January 8, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 9, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 9, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 10, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Monday, February 24, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

zilbrysq myasthenia gravis treatment prevention preparations human pharmaceutical